Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine plus intralesional corticosteroid versus colchicine plus topical triamcinolone for idiopathic granulomatous mastitis
IRCT20100706004329N13Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in Granulomatous lobular mastitis (GLM) comparing Oral colchicine + intralesional corticosteroid injection with Oral colchicine + topical triamcinolone (2 arms). Primary endpoint: response to treatment. Started May 2025; status: completed.
02
Drugs
colchicinetriamcinolone
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on IRCT20100706004329N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100706004329N13.